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Introduction 
Contemporary magnetic resonance angiography (MRA) is commonly performed using T1-lowering gadolinium (Gd), time-of-flight (TOF) imaging, or phase contrast 
(PC) angiography. While Gd based MRA has been established as the gold standard for many applications, it may not easily be tolerated in patients with renal 
insufficiency. Unfortunately, the alternatives TOF and PC angiography are artifact-prone since the contrast is blood-flow dependent. Recently, highly sophisticated spin 
labeling techniques have been proposed [1,2]. However, spin labeling methods are also in-flow dependent, which may lead to additional image artifacts in regions of 
slow or turbulent flow such as stenoses and bifurcations. Therefore, an alternative flow-independent angiographic technique without Gd may be most valuable. To 
address this need, we propose MR imaging of a perfluorocarbon compound that, after intravenous injection, is only present in the lumen blood-pool. Perfluorocarbons 
such as perfluoro-15-crown-5-ether (CE) are excellent candidates for lumen imaging: they are chemically inert, have a long retention time when emulsified, are non-
toxic and are in several phase 3 FDA trials [3], which also opens up the outlook for translation into the human setting. For these reasons, we have developed a 19F MRI 
high-field MRA methodology using CE emulsions, have tested it in vitro and have, for the first time, explored its utility for 19F angiography in vivo. 
    
Materials and Methods 
All experiments were performed on a Varian 9.4 T horizontal bore animal 
spectrometer in combination with a dedicated custom-built 18 mm 
diameter quadrature surface coil that is tunable to both 1H and 19F. The 
study was approved by the local animal ethics committee. Preparation of a 
10% CE emulsion was carried out as previously described [4]. 0.5 ml of 
the emulsion were added to 1.4 ml human venous blood as well as to 1.4 
ml saline (approximating arterial blood) to determine the T1 and T2 
relaxation times of the CE with spatially unlocalized inversion recovery 
and spin echo sequences, respectively. Next, a dilution series (from 49 
mM CE in the saline sample above in 5 steps to 198 µM) was created to 
determine the detection limit of the optimized sequence within 20 min of 
measurement time. 19F images in this series were postprocessed with a 4-
pixel disk filter and thresholding at 90% of the maximum signal intensity. 
In the in vivo part of the study, male balb/c mice (n=2, w≈29 g) were 
anesthetized and injected with 12 µl/g of the CE emulsion through the tail 
vein. The animals were positioned supine with the surface coil localized at 
the anterior abdomen. After acquisition of anatomic gradient echo (GRE) 
1H images (30x30x2 mm2, 128x128, TE=2.9 ms, TR=50 ms, 8 slices, 16 
averages), the coil was tuned to 19F and GRE imaging at the same 
anatomical level was repeated (64x64, TE=2.7 ms, TR=40 ms, 512 
averages, acquisition time = 21 min). In the aorta and in the heart 
chambers, the CNR was measured. The 19F images were then 
postprocessed for better visualization with a 3-pixel Gaussian filter and a 
thresholding at 20% of the maximum signal. 
 
Results and Discussion 
In vitro, the 19F T1 relaxation time was very similar in saline and blood 
(1396±5 and 1351±8 ms), while the T2 was drastically reduced by the 
presence of deoxyhemoglobin (440±25 to 25±2 ms). In the dilution series, 
the SNR was ranging from ~86 to ~1 and the CE detection limit within 
20min of scanning time was 390 μM CE with an SNR of ~2 (Fig. 1a-c). 
This is well consistent with the 
predicted detection limit reported 
in the literature [4]. In the in vivo 
part of the study, the 19F images 
clearly, selectively and exclusively 
visualized the blood-pool at 
different anatomical levels with high contrast (Fig. 1e,f,h,i). These 19F images consistently co-registered with the corresponding 
anatomy on the proton images and do not only visualize the lumen of vascular structures but also the blood-pool in the left and 
the right ventricle. Considering a relatively long scanning time of 20 min, these findings are in agreement with the long expected 
intravascular retention time of 19F CE in the blood-pool. The average CNR in the descending aorta and portal vein was ~15, 
while it was ~50 in the heart. In conclusion, intravenously administered 19F is well-suited for a selective and exclusive 
visualization of the vasculature and the heart chambers in vivo. The high CNR and long intravascular containment makes 19F 
MRI a promising alternative flow-independent angiographic MR technique. Since perfluoro-15-crown-5-ether is safe, a 
translation into the human setting may be possible. In addition, it has already successfully been demonstrated that CE 19F can 
detect inflammation [4,5] in vivo. Therefore, it remains to be investigated whether the above-described methodology may be 
further exploited to simultaneously visualize 19F plaque macrophage uptake in atherosclerosis. 
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Figure 2. 19F maximum-intensity 
projection (MIP) of several coronal 
slices, exclusively showing several 
anatomical structures: the right 
ventricle (RV), left ventricle (LV), 
descending aorta (DA), renal 
artery (RA) and liver (L). 
Figure 1. Three series of 3 images, with 1H reference images in the left column, 19F 
images in the middle and the 19F overlaid as hot iron on 1H images in the right column. 
a-c: Demonstration of the detection limit of 390 µl in two Eppendorf tubes, with b 
showing the location of the tube without CE as a dashed circle. d-f: Axial slice at the 
level of the liver. In e, blood-vessels in the liver can exclusively be seen. f: HA=hepatic 
artery, DA=descending aorta. g-i: Coronal slice including the heart (LV=left ventricle, 
RV=right ventricle), the descending aorta (DA) and the kidneys (dashed arrows in i). 
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